Trump’s 100% tariffs on branded drugs: Which Indian pharma stocks are most vulnerable? Experts weigh in
For Indian pharmaceutical exports, the US represents the primary market, comprising about 35% of total exports, with a value reaching about $10 billion in FY25. (AI image) US President Donald Trump’s move to impose 100% tariffs on branded and patented pharmaceutical exports has rattled Indian pharma stocks, even though most companies earn from US markets…
Russian oil purchase: How 500% tariff could upend $120 billion India-US trade – explained
A 500% tariff would effectively shut down India’s goods and services exports to the United States. (AI image) Will India face 500% tariffs from the US soon? It’s a question that’s on the mind of everyone after US Senator Lindsey Graham said that President Donald Trump has given the go ahead for a bill that…
